2023
DOI: 10.3390/app13042588
|View full text |Cite
|
Sign up to set email alerts
|

Somatotropin Penetration Testing from Formulations Applied Topically to the Skin

Abstract: Growth hormone (somatotropin—STH) deficiency therapy requires daily injections of recombinant human growth hormone. The FDA approved treatment with STH with one dose per week for the first time in 2021. However, injectable drug application is accompanied by numerous inconveniences. Therefore, an attempt was made to formulate a less invasive STH formulation for topical application to the skin. A substrate was prepared based on a polymer, methylcellulose (MC), into which STH was introduced at a concentration of … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2

Relationship

1
1

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 50 publications
0
1
0
Order By: Relevance
“…The prepared hydrogel formulations were inspected visually for their color, appearance, uniformity and consistency, stickiness, greasiness and greasing, and adhesion [59]. The method of performing the tests was previously described by Siemiradzka et al [60].…”
Section: Visual and Sensory Inspection Of Prepared Formulationsmentioning
confidence: 99%
“…The prepared hydrogel formulations were inspected visually for their color, appearance, uniformity and consistency, stickiness, greasiness and greasing, and adhesion [59]. The method of performing the tests was previously described by Siemiradzka et al [60].…”
Section: Visual and Sensory Inspection Of Prepared Formulationsmentioning
confidence: 99%